Literature DB >> 12144538

Activity of all-trans-retinoic acid in a case of central nervous system extramedullary relapse of acute promyelocytic leukemia.

Francesca Patriarca1, Carla Filì, Antonella Geromin, Alessandra Sperotto, Simonetta Prosdocimo, Renato Fanin.   

Abstract

We describe a patient with an acute promyelocytic leukemia (APL) previously treated with two courses of cytarabin, idarubicin and all-trans retinoic acid (ATRA), who presented a medullary and meningeal relapse after 8 months of complete remission. A diagnosis of central nervous system (CNS) involvement was based on the appearance of APL blasts in the cerebrospinal fluid (CSF); magnetic resonance (MR) imaging was negative. The neurological symptoms were not evident at the time of recognition of the medullary recurrence, but appeared a few days later, when the patient had already received a reinduction treatment. When the CSF was first examined, showing atypical promyelocytes, there was no excess of blasts on bone-marrow examination. The patient was treated with ATRA and intrathecal administrations of cytoxic drugs, achieving a complete long-lasting CNS remission. The appearance of mature myeloid cells in the CSF during this treatment suggested a possible differentiating effect of ATRA towards extramedullary relapse.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12144538     DOI: 10.1034/j.1600-0609.2002.01660.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  7 in total

1.  Promyelocytic sarcoma of the spine: a case report and review of the literature.

Authors:  Leonardo Pacilli; Francesco Lo Coco; Safaa Mahmoud Ramadan; Laura Giannì; Alberto Pingi; Daniele Remotti; Ignazio Majolino
Journal:  Adv Hematol       Date:  2010-03-18

Review 2.  How I treat children and adolescents with acute promyelocytic leukaemia.

Authors:  Oussama Abla; Raul C Ribeiro
Journal:  Br J Haematol       Date:  2013-09-30       Impact factor: 6.998

3.  Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia.

Authors:  Jiong Hu; Yuan-Fang Liu; Chuan-Feng Wu; Fang Xu; Zhi-Xiang Shen; Yong-Mei Zhu; Jun-Min Li; Wei Tang; Wei-Li Zhao; Wen Wu; Hui-Ping Sun; Qiu-Sheng Chen; Bing Chen; Guang-Biao Zhou; Arthur Zelent; Samuel Waxman; Zhen-Yi Wang; Sai-Juan Chen; Zhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

4.  Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience.

Authors:  Arturo Vega-Ruiz; Stefan Faderl; Zeev Estrov; Sherry Pierce; Jorge Cortes; Hagop Kantarjian; Farhad Ravandi
Journal:  Int J Hematol       Date:  2009-04-02       Impact factor: 2.490

5.  Extramedullary relapse in lumbar spine of patient with acute promyelocytic leukemia after remission for 16 years: a case report and literature review.

Authors:  Zhengmei He; Shandong Tao; Yuan Deng; Yue Chen; Lixiao Song; Banghe Ding; Kankan Chen; Liang Yu; Chunling Wang
Journal:  Int J Clin Exp Med       Date:  2015-12-15

6.  Extramedullary disease in acute promyelocytic leukemia: two-in-one disease.

Authors:  Francesco Albano; Giorgina Specchia
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-12-21       Impact factor: 2.576

Review 7.  Meningeal relapse in a patient with acute promyelocytic leukemia: a case report and review of the literature.

Authors:  Sung Hwa Bae; Hun Mo Ryoo; Hee Soon Cho; Jae Lyun Lee; Kyung Hee Lee; Myung Soo Hyun
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.